David H. Kirske
Net Worth

Last updated:

What is David H. Kirske net worth?

The estimated net worth of Mr. David H. Kirske is at least $4,310,136 as of 3 Jan 2023. He has earned $2,263,176 from insider trading and has received compensation worth at least $2,046,960 in CTI BioPharma Corp..

What is the salary of David H. Kirske?

Mr. David H. Kirske salary is $511,740 per year as Executive Vice President, Chief Financial Officer & Sec. in CTI BioPharma Corp..

How old is David H. Kirske?

Mr. David H. Kirske is 71 years old, born in 1954.

What stocks does David H. Kirske currently own?

As insider, Mr. David H. Kirske owns shares in one company:

Company Title Shares Price per share Total value
CTI BioPharma Corp. (CTIC) Executive Vice President, Chief Financial Officer & Sec. 17,127 $0 $0

What does CTI BioPharma Corp. do?

CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd.; S*BIO Pte Ltd.; and Baxalta. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington.

CTIC logo
CTIC
CTI BioPharma Corp.

David H. Kirske insider trading

CTI BioPharma Corp.

Mr. David H. Kirske has made 11 insider trades between 2021-2023, according to the Form 4 filled with the SEC. Most recently he sold 27,021 units of CTIC stock worth $162,423 on 3 Jan 2023.

The largest trade he's ever made was exercising 200,000 units of CTIC stock on 10 Mar 2021. As of 3 Jan 2023 he still owns at least 17,127 units of CTIC stock.

Transaction Date Security Shares Price per share Total value Source
Sale
common stock 27,021 $6.01 $162,423
Option
Non-Qualified Stock Option (right to buy) 27,021 $0.95 $25,643
Option
common stock 27,021 $0.95 $25,643
Option
Non-Qualified Stock Option (right to buy) 1,047 $0.95 $994
Option
common stock 800 $0.95 $759
Option
common stock 1,047 $0.95 $994
Sale
common stock 1,047 $6.01 $6,292
Option
Non-Qualified Stock Option (right to buy) 12,000 $0.95 $11,388
Option
Non-Qualified Stock Option (right to buy) 800 $0.95 $759
Option
common stock 12,000 $0.95 $11,388
Option
Non-Qualified Stock Option (right to buy) 13,174 $0.95 $12,502
Option
common stock 13,174 $0.95 $12,502
Sale
common stock 13,174 $6 $79,044
Option
Non-Qualified Stock Option (right to buy) 609 $0.95 $578
Option
Non-Qualified Stock Option (right to buy) 1,400 $0.95 $1,329
Option
common stock 609 $0.95 $578
Option
common stock 1,400 $0.95 $1,329
Sale
common stock 609 $6.27 $3,818
Option
common stock 100 $0.95 $95
Option
Non-Qualified Stock Option (right to buy) 100 $0.95 $95
Sale
common stock 300 $6.25 $1,875
Option
common stock 300 $0.95 $285
Option
Non-Qualified Stock Option (right to buy) 300 $0.95 $285
Option
Non-Qualified Stock Option (right to buy) 139,841 $0.95 $132,709
Option
common stock 139,841 $0.95 $132,709
Sale
common stock 139,841 $6.05 $845,619
Sale
common stock 100 $6.01 $601
Option
common stock 100 $0.95 $95
Option
Non-Qualified Stock Option (right to buy) 100 $0.95 $95
Option
Non-Qualified Stock Option (right to buy) 800 $0.95 $759
Option
common stock 800 $0.95 $759
Sale
common stock 22,592 $6.02 $136,004
Option
Non-Qualified Stock Option (right to buy) 22,592 $0.95 $21,440
Option
common stock 22,592 $0.95 $21,440
Sale
common stock 50,000 $6.25 $312,500
Option
common stock 50,000 $3.3 $165,000
Option
Non-Qualified Stock Option (right to buy) 50,000 $3.3 $165,000
Option
Non-Qualified Stock Option (right to buy) 10,000 $1 $10,000
Option
common stock 10,000 $1 $10,000
Option
Non-Qualified Stock Option (right to buy) 10,000 $0.95 $9,490
Option
common stock 10,000 $0.95 $9,490
Sale
common stock 10,000 $5.5 $55,000
Sale
Stock Option (right to buy) 200,000 $3.3 $660,000

CTI BioPharma Corp. key executives

CTI BioPharma Corp. executives and other stock owners filed with the SEC: